Gupta, Anjali <br/><br/>
Resiquimod inhibits Newcastle disease virus replication by modulating host cytokines: An understanding towards its possible therapeutics.  [electronic resource] 

 -  Cytokine  01 2020 
 - 154811 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2019.154811  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Cell Line<br/>Chick Embryo<br/>Cytokines--metabolism<br/>Fibroblasts--metabolism<br/>Imidazoles--pharmacology<br/>Immunity, Innate--drug effects<br/>Interferon-alpha--metabolism<br/>Interferon-gamma--metabolism<br/>Interleukin-18--metabolism<br/>Interleukin-1beta--metabolism<br/>Lung--drug effects<br/>Newcastle disease virus--drug effects<br/>Poultry Diseases--drug therapy<br/>Spleen--drug effects<br/>Toll-Like Receptor 7--agonists<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Virus Replication--drug effects